| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA103048
Max Phase: Preclinical
Molecular Formula: C11H22N2
Molecular Weight: 182.31
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CN1CCCC(C2CCCN2C)C1
Standard InChI: InChI=1S/C11H22N2/c1-12-7-3-5-10(9-12)11-6-4-8-13(11)2/h10-11H,3-9H2,1-2H3
Standard InChI Key: LGMQKWYKBNHSOY-UHFFFAOYSA-N
Associated Targets(non-human)
Creatine transporter 104 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 182.31 | Molecular Weight (Monoisotopic): 182.1783 | AlogP: 1.42 | #Rotatable Bonds: 1 |
| Polar Surface Area: 6.48 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 10.30 | CX LogP: 1.18 | CX LogD: -2.10 |
| Aromatic Rings: 0 | Heavy Atoms: 13 | QED Weighted: 0.60 | Np Likeness Score: 0.22 |
References
| 1. Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD.. (2004) Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter., 14 (12): [PMID:15149650] [10.1016/j.bmcl.2004.04.020] |
Source
Source(1):